Viberzi (eluxadoline) is not classified as a controlled substance. [1]
What is Viberzi used for?
Viberzi is a prescription medication used to treat irritable bowel syndrome with diarrhea (IBS-D) in adults. [1]
How does Viberzi work?
Eluxadoline, the active ingredient in Viberzi, is a mixed mu-opioid receptor antagonist and delta-opioid receptor agonist, and a kappa-opioid receptor agonist. It works by decreasing the movement of fluid into the colon and reducing the speed at which food passes through the intestines. [1]
What are the potential side effects of Viberzi?
Common side effects of Viberzi include constipation, nausea, and abdominal pain. [1] More serious potential side effects include pancreatitis, sphincter of Oddi dysfunction, and constipation that may lead to fecal impaction or bowel obstruction. [1] Individuals who have had their gallbladder removed are at a higher risk for serious side effects. [1]
What are the risks associated with Viberzi?
There are risks associated with Viberzi use, particularly for patients who have had their gallbladder removed. These risks include pancreatitis and sphincter of Oddi dysfunction, which can be serious and may require hospitalization. [1] It is important for patients to discuss their medical history, including whether their gallbladder has been removed, with their healthcare provider before starting Viberzi. [1]
Where can I find more information about drug patents?
For information on drug patents, including those related to medications like Viberzi, you can consult DrugPatentWatch.com. [2]